Clinical pharmacokinetics of methotrexate

DD Shen, DL Azarnoff - Clinical pharmacokinetics, 1978 - Springer
The absorption of methotrexate following intramuscular injection and oral administration of
small doses (>30mg/m 2 ) is rapid and complete, whereas with oral doses in excess of 80mg/…

Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens

JK Reddy, DL Azarnoff, CE Hignite - Nature, 1980 - nature.com
Several drugs, including clofibrate (ethyl-a-p-chlorophenoxyisobutyrate) 1 , are now available
for the treatment of hyperlipidaemias 2,3 and others are in the process of preclinical or …

Drugs and drug metabolites as environmental contaminants: chlorophenoxyisobutyrate and salicylic acid in sewage water effluent

C Hignite, DL Azarnoff - Life Sciences, 1977 - Elsevier
Chlorophenoxyisobutyrate (CPIB) and salicylic acid, the metabolites of clofibrate and aspirin,
were quantitated by gas chromatography-mass spectrometry in the effluent of a sewage …

Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers.

JB Dyck, M Maze, C Haack, DL Azarnoff… - …, 1993 - europepmc.org
Background This investigation extended the pharmacokinetic analysis of our previous study,
of intravenous dexmedetomidine in 10 healthy male volunteers, and prospectively tested …

Clinical complications of corticosteroid therapy: a selected review

CA Dujoune, DL Azarnoff - Medical Clinics of North America, 1973 - Elsevier
The clinical complications of corticosteroid therapy are as protean as the many therapeutic
indications for which their use has been suggested. For a comprehensive review and …

Kinetics, salivary excretion of amphetamine isomers, and effect of urinary pH

SH Wan, SB Matin, DL Azarnoff - Clinical Pharmacology & …, 1978 - Wiley Online Library
Amphetamine was administered to healthy subjects as the racemic mixture and as (+)‐and (−)‐isomers
under conditions of urine acidification and alkalinization. Plasma and saliva …

Phenytoin: pharmacokinetics and bioavailability

…, CV Manion, DL Azarnoff - Clinical Pharmacology & …, 1976 - Wiley Online Library
The pharmacokinetics of a single 300‐mg oral and intravenous and 14 daily 300‐mg oral
doses of phenytoin were studied in 6 healthy volunteers. The mean plasma elimination t ½ …

Correlation between plasma diphenhydramine level and sedative and antihistamine effects

…, DW Shoeman, CE Hignite, DL Azarnoff - Clinical …, 1978 - Wiley Online Library
The sedative and antihistamine effects of diphenhydramine were assessed in relation to
plasma concentration after placebo, diphenhydramine 50 mg intravenously, and …

Pharmacokinetics of methotrexate

DH Huffman, SH Wan, DL Azarnoff… - Clinical …, 1973 - Wiley Online Library
… Patients with various types of inoperable carcinomas served as subjects for this study and,
with the exception of VG, all had normal renal function (creatinine less than 1.5 mg/ dl) and …

Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator,[4-chloro-6-(2, 3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643), in rat and mouse …

JK Reddy, MS Rao, DL Azarnoff, S Sell - Cancer research, 1979 - AACR
Long-term effects of Wy-14,643 ([4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid), a
potent hepatic peroxisome proliferator structurally unrelated to the clinically used drug …